New York City, United States -- With the outbreak of COVID-19 in worldwide and stipulated lockdown, the healthcare sector is witnessing an unprecedented slowdown as per EY-FICCI study titled, ˜COVID-19 impact assessment for healthcare sector and key financial measures recommendations for the sector'. The study is predicated on an assessment of healthcare players within the country to assess the economic impact of the COVID-19 pandemic and provides recommendations on the fiscal stimulus measures it needs within the coming months.
Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global hospital-acquired pneumonia prevention market. The report has been published by Persistence Market Research and is titled, œHospital-Acquired Pneumonia Prevention Market:
Global Industry Analysis 2013 “ 2017 and Forecast 2018 “ 2026. The US$ 795 Mn market is likely to exhibit a CAGR of 4.7%, reaching a value in excess of US$ 1,100 Mn by the end of 2026.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/22768
Company Profile
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/22768
Key Market Drivers: Overview
Immunosenescence will continue to remain a key factor driving the demand for prevention of hospital-acquired pneumonia worldwide. Expanding geriatric population and the following ceasing immunity are expected to sustain the need for regulating the pneumonia infection acquired in hospitals. Increasing cases of chronic ailments resulting in gradually weakening immune system also mark another strong driver to market growth in next few years.
Ceasing immunity in turn extends patients' stay at hospitals, which makes them more prone to acquiring disease infections such as pneumonia. The global market for hospital-acquired pneumonia prevention is anticipated to gain continued thrust from such instances, including people of all age groups.
Amplifying patient pool across the globe coupled with an increasing number of hospitals in developed as well as developing economies are presumed to push the market scenario up in near future. Moreover, several countries are mandating the implementation of pneumonia prevention protocols, which is apprehended to create multiple growth opportunities in upcoming years.
The growth of market in developing economies will be specifically accelerated by soaring burden of pneumonia instances among the Southeast Asian Countries. Medical tourism industry is flourishing in emerging countries such as India is expected to fuel the hospital-acquired pneumonia cases and thereby, elevate the demand for its prevention throughout the next few years.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/22768
By product type, the market has been segmented into:
By end-user, the market is classified as:
Regional Analysis: Overview
Regional segmentation of the global hospital-acquired pneumonia prevention classifies the market as North America, Latin America, Europe, Asia Pacific excluding China, China, and Middle East & Africa. Among these, North America will remain dominant over all other regional markets primarily owing to a favorable initiative by the US Government to incentivize innovation in the field of antibacterial drugs.
This governmental activity aims at addressing the emergency demand for better prevention measures against bacterial infections. Moreover, the demand for high-quality oral care products in ICU sections of hospitals has been escalating due to rising chronic kidney disease instances since the recent past. Europe secures the second position in terms of market size, APEC is foreseen to be the third largest lucrative region; whereas China is projected to be the most promisingly emerging market with the largest estimated CAGR value of around 5.5%.
| Company Name | Contact Person | Contact Number | Email Id | Website | Address |
|---|---|---|---|---|---|
| Persistence Market Research |
NutraBio Labs Inc., a dietary supplement manufacturer in Middlesex, NJ, has dedicated part of its GMP manufacturing facility to making an im...Read More
Taking temperature and tracking blood oxygen levels helps individuals with COVID-19 monitor their condition at home or in isolation at the clinic to g...Read More
Celebrity chef Guy Fieri?s bright smile and goatee may have been tucked behind a cloth mask while serving meals to medical staff at Sutter Santa ...Read More
Many states that shared budget projections in response to a new KFF survey of state Medicaid officials report that they expect to see Medica...Read More
The "Impact on Consumer Behavior in the Americas: COVID-19 Survey Snapshot" report has been added to ResearchAndMarkets.com's offering.The publisher i...Read More
